Novartis, the world’s leading provider of Artemisinin-based combination therapies against malaria has announced developments of the next generation of medicines for malaria. Novartis East...
Healing Blends Global in conjunction with Uzima University Medical School will conduct a Sickle Cell double-blind study in Kisumu, Kenya. The study will evaluate the effectiveness of Even Flo, an all-natural supplement, in reducing the frequency of crises in sickle cell patients. This study will...